[Featured Stocks] Rapid Increase in COVID-19 Patients... Diagnostic Kit Stocks '↑'
Diagnostic kit stocks are showing strength. It appears that the recent surge in COVID-19 patients has had an impact.
Suzentec was trading at 7,790 won as of 10:11 AM on the 2nd, up 1,580 won (25.44%) compared to the previous trading day. LabGenomics, Humasis, and Seegene are also showing strong performance.
Hot Picks Today
"Stock Surges from 255,000 Won to Over 2.2 Million"... Up 773% Yet Set to Climb Higher [This Week's Hot Stock]
- Despite a 10% Plunge, Target Price Raised from 2.5 Million to 4.2 Million Won... Why SK hynix's Target Price Was Increased [Click e-Stock]
- "Amputation with Scissors, Hard to Believe...But a Complicated Situation" — Practicing Doctor Weighs In on Incheon Nursing Hospital Controversy
- Buffett's Disciple Pabrai: "Never Sell Samsung or SK hynix"
- Was It Really Drugs? Shocking Turn as Suwon "Fentanyl Suspect" Tests Negative in Forensic Report: "I Was Just Weak"
According to the Korea Disease Control and Prevention Agency, the number of new COVID-19 hospitalizations increased 5.1 times over the past four weeks, with 91 cases in the first week of July, 148 in the second week, 225 in the third week, and 465 in the fourth week. The virus detection rate rose from 7.4% in the fourth week of June to 24.6% in the third week of July, an increase of 17.2 percentage points over four weeks.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.